Symbol="ITRM"
AssetType="Common Stock"
Name="Iterum Therapeutics PLC"
Description="Iterum Therapeutics plc, a clinical-stage pharmaceutical company, is engaged in the development of anti-infectives for multidrug resistant pathogens in Ireland and the United States. The company is headquartered in Dublin, Ireland."
CIK="1659323"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="BLOCK 2 FLOOR 3, HARCOURT CENTRE, HARCOURT STREET, DUBLIN, IE"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="13110600"
EBITDA="-29762000"
PERatio="None"
PEGRatio="None"
BookValue="1.48"
DividendPerShare="0"
DividendYield="0"
EPS="-4.47"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.277"
ReturnOnEquityTTM="-1.504"
RevenueTTM="0"
GrossProfitTTM="37000"
DilutedEPSTTM="-4.47"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-1"
AnalystTargetPrice="1"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="1349.79"
PriceToBookRatio="0.445"
EVToRevenue="105.22"
EVToEBITDA="0.534"
Beta="1.588"
num_52WeekHigh="4.348"
num_52WeekLow="0.601"
num_50DayMovingAverage="1.094"
num_200DayMovingAverage="1.167"
SharesOutstanding="12980800"
DividendDate="None"
ExDividendDate="None"
symbol="ITRM"
open="1.00"
high="1.02"
low="0.97"
price="1.01"
volume="133114.00"
latest_trading_day="2023-08-10"
previous_close="1.02"
change="-0.01"
change_percent="-0.9804%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="61"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="39"
Volume_recent_avg="56010"
Change_recent_avg="0.01"
Delta_recent_avg="0.07"
Variance_recent_avg="0.03"
Change_ratio_recent_avg="-0.1"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="39"
Aroon_momentum_negative="61"
image_negative_thumbnail_id_1="154"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0022.jpeg"
image_negative_thumbnail_id_2="1097"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0130.jpeg"
image_neutral_thumbnail_id_1="592"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0007.jpeg"
image_neutral_thumbnail_id_2="588"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0011.jpeg"
image_positive_thumbnail_id_1="705"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0003.jpeg"
image_positive_thumbnail_id_2="985"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0147.jpeg"
image_professor_thumbnail_id_1="1173"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0007.jpeg"
image_professor_thumbnail_id_2="1185"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0019.jpeg"
